CBC·1 min read·easy
U.S. FDA approves first mRNA flu shot from Moderna
✦AI Summary
The U.S. FDA has granted approval for Moderna's mRNA-based flu vaccine for individuals aged 50 and older. This decision marks a reversal of the agency's previous refusal to review the vaccine, clearing the path for its distribution in the United States.
The U.S. Food and Drug Administration has approved Moderna's mRNA-based flu vaccine for people aged 50 and older — a complete reversal from an earlier refusal to review the shot. The approval clears the way for the vaccine to be available in the U.S... [4394 chars]
healthbusiness
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in